Biotricity, Inc.
BTCY
$0.6332
$0.00280.44%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.00% | 16.50% | 21.73% | 12.99% | 5.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.00% | 16.50% | 21.73% | 12.99% | 5.99% |
| Cost of Revenue | -9.71% | -20.04% | 6.22% | -9.45% | -24.05% |
| Gross Profit | 31.89% | 31.07% | 27.49% | 23.00% | 23.30% |
| SG&A Expenses | -27.90% | -29.24% | -20.53% | -35.51% | -15.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.82% | -26.75% | -10.97% | -29.59% | -19.09% |
| Operating Income | 125.24% | 71.90% | 86.82% | 85.92% | 51.79% |
| Income Before Tax | 81.81% | 53.72% | 56.23% | 57.68% | -8.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 81.81% | 53.72% | 56.23% | 57.68% | -8.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 81.81% | 53.72% | 56.23% | 57.68% | -8.25% |
| EBIT | 125.24% | 71.90% | 86.82% | 85.92% | 51.79% |
| EBITDA | 125.41% | 71.93% | 86.92% | 85.98% | 51.82% |
| EPS Basic | 94.15% | 83.55% | 83.96% | 83.34% | -19.17% |
| Normalized Basic EPS | 88.93% | 83.33% | 84.00% | 83.52% | 40.09% |
| EPS Diluted | 94.15% | 83.50% | 83.96% | 83.34% | -19.17% |
| Normalized Diluted EPS | 88.93% | 83.33% | 84.00% | 83.52% | 40.09% |
| Average Basic Shares Outstanding | 85.50% | 179.18% | 169.87% | 155.73% | 61.89% |
| Average Diluted Shares Outstanding | 85.50% | 179.18% | 169.87% | 155.73% | 61.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.72% | -- | -1.21% | -1.42% | -0.83% |